ID   SYV_BIFLS               Reviewed;         911 AA.
AC   B7GTW0; E8MP49;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   03-AUG-2022, entry version 84.
DE   RecName: Full=Valine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02005};
DE            EC=6.1.1.9 {ECO:0000255|HAMAP-Rule:MF_02005};
DE   AltName: Full=Valyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02005};
DE            Short=ValRS {ECO:0000255|HAMAP-Rule:MF_02005};
GN   Name=valS {ECO:0000255|HAMAP-Rule:MF_02005};
GN   OrderedLocusNames=Blon_0275, BLIJ_0279;
OS   Bifidobacterium longum subsp. infantis (strain ATCC 15697 / DSM 20088 / JCM
OS   1222 / NCTC 11817 / S12).
OC   Bacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae;
OC   Bifidobacterium.
OX   NCBI_TaxID=391904;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15697 / DSM 20088 / JCM 1222 / NCTC 11817 / S12;
RX   PubMed=19033196; DOI=10.1073/pnas.0809584105;
RA   Sela D.A., Chapman J., Adeuya A., Kim J.H., Chen F., Whitehead T.R.,
RA   Lapidus A., Rokhsar D.S., Lebrilla C.B., German J.B., Price N.P.,
RA   Richardson P.M., Mills D.A.;
RT   "The genome sequence of Bifidobacterium longum subsp. infantis reveals
RT   adaptations for milk utilization within the infant microbiome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:18964-18969(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15697 / DSM 20088 / JCM 1222 / NCTC 11817 / S12;
RX   PubMed=21270894; DOI=10.1038/nature09646;
RA   Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., Tobe T.,
RA   Clarke J.M., Topping D.L., Suzuki T., Taylor T.D., Itoh K., Kikuchi J.,
RA   Morita H., Hattori M., Ohno H.;
RT   "Bifidobacteria can protect from enteropathogenic infection through
RT   production of acetate.";
RL   Nature 469:543-547(2011).
CC   -!- FUNCTION: Catalyzes the attachment of valine to tRNA(Val). As ValRS can
CC       inadvertently accommodate and process structurally similar amino acids
CC       such as threonine, to avoid such errors, it has a 'posttransfer'
CC       editing activity that hydrolyzes mischarged Thr-tRNA(Val) in a tRNA-
CC       dependent manner. {ECO:0000255|HAMAP-Rule:MF_02005}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-valine + tRNA(Val) = AMP + diphosphate + L-valyl-
CC         tRNA(Val); Xref=Rhea:RHEA:10704, Rhea:RHEA-COMP:9672, Rhea:RHEA-
CC         COMP:9708, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57762,
CC         ChEBI:CHEBI:78442, ChEBI:CHEBI:78537, ChEBI:CHEBI:456215; EC=6.1.1.9;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02005};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02005}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02005}.
CC   -!- DOMAIN: ValRS has two distinct active sites: one for aminoacylation and
CC       one for editing. The misactivated threonine is translocated from the
CC       active site to the editing site. {ECO:0000255|HAMAP-Rule:MF_02005}.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC       ValS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02005}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001095; ACJ51401.1; -; Genomic_DNA.
DR   EMBL; AP010889; BAJ67873.1; -; Genomic_DNA.
DR   RefSeq; WP_012576712.1; NZ_JDTT01000027.1.
DR   AlphaFoldDB; B7GTW0; -.
DR   SMR; B7GTW0; -.
DR   PRIDE; B7GTW0; -.
DR   EnsemblBacteria; ACJ51401; ACJ51401; Blon_0275.
DR   KEGG; bln:Blon_0275; -.
DR   KEGG; blon:BLIJ_0279; -.
DR   PATRIC; fig|391904.8.peg.280; -.
DR   HOGENOM; CLU_001493_0_2_11; -.
DR   OMA; RQWYIRN; -.
DR   Proteomes; UP000001360; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004832; F:valine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006438; P:valyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR   CDD; cd07962; Anticodon_Ia_Val; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   Gene3D; 3.90.740.10; -; 1.
DR   HAMAP; MF_02005; Val_tRNA_synth_type2; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002300; aa-tRNA-synth_Ia.
DR   InterPro; IPR033705; Anticodon_Ia_Val.
DR   InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR   InterPro; IPR022874; Valine-tRNA_ligase_type_2.
DR   InterPro; IPR002303; Valyl-tRNA_ligase.
DR   PANTHER; PTHR11946; PTHR11946; 1.
DR   Pfam; PF08264; Anticodon_1; 1.
DR   Pfam; PF00133; tRNA-synt_1; 2.
DR   PRINTS; PR00986; TRNASYNTHVAL.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF50677; SSF50677; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   3: Inferred from homology;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase;
KW   Nucleotide-binding; Protein biosynthesis.
FT   CHAIN           1..911
FT                   /note="Valine--tRNA ligase"
FT                   /id="PRO_1000189252"
FT   REGION          882..911
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           57..67
FT                   /note="'HIGH' region"
FT   MOTIF           599..603
FT                   /note="'KMSKS' region"
FT   BINDING         602
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02005"
SQ   SEQUENCE   911 AA;  102170 MW;  C2AFA5B04224C76C CRC64;
     MTEGKSIINA NLTPLPDKVG VDGLEDKWRA VWDEDGTYKF RNTRDRKAVY SIDTPPPTVS
     GSLHVGHVFS YTHTDVIARY KRMRGYDVFY PMGWDDNGLP TERRVQNYYG VRVDVSLPYD
     PDFKPPFEGT DGKKIDAKDQ VPISRKNFIE LCERLTAQDE KLFEALWRKL GLSIDWSQTY
     HTIGQHPQRV AQKAFLRNLA RGEAYQQDAP GLWDVTFQTA VAQAELESRE YPGFYHKVAF
     RFEDGTPIYI ETTRPELLAA CTSLIANPND ERYKQYFGQY VYSPLFKVKV PILAHPAAEM
     DKGAGIAMCC TFGDVTDVEW WRDLKLPTRP IIQRNGRIVM DTPDWIEDPA GREVFAETAG
     KTTFSARKII VDKLRESGDL DGEPTPTKRM TNFYEKGDKP LEIVTSRQWY LKNGGTDAKL
     NAELIERGKE LEFHPDFMRV RYENWVHGLN GDWLISRQRF FGVPFPLWYP VNASGEPDYD
     HPITPSEDRL PIDPTIDVPE GYDESQRDVP GGFTAEKDIM DTWATSSLTP QIVTHWAEPD
     EASQALFKST FPMDLRPQGQ DIIRTWLFST VDRAHLENKC LPWAHATLSG WILDPDHKKM
     SKSKGNVVVP NEPIEKFGAD AVRYWAAAAR LGLDATYDIG QMKIGRRLAI KLLNATKFAL
     AIGREDENHH VGAAAEAAWN PADVTEPLDR AAMAKLAVVV RQATEALESY EHSKALEVIE
     SYFWQFCDDY IELVKNRAYG TPDEHGNVPS EKAVKSARTA LGLGLDAFAR LLAPYLPYAT
     EEVWSWMHAG SGSVHRAAWP VVDPYVEAAT GASPELLTWA GKAVEQLRKI KSEAKVSMKT
     PILSVALSAA SEGVDAIHAA LGDIAQAGRV VGKFDLVAKH AEESAAEDAP ETEVAVEASE
     LGEPPVKKPK H